De Sarro A - Search Results

1

Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice.

De Sarro G, Nava F, Aguglia U, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Neuropharmacology. 1996 Feb;35(2):153-8. doi: 10.1016/0028-3908(95)00174-3. Neuropharmacology. 1996. PMID: 8734483

2

Effects of some calcium antagonists upon the activity of common antiepileptic compounds on sound-induced seizures in DBA/2 mice.

De Sarro GB, De Sarro A, Trimarchi GR, Nistico' G. De Sarro GB, et al. Among authors: de sarro a. Gen Pharmacol. 1992 Jan;23(1):75-82. doi: 10.1016/0306-3623(92)90051-k. Gen Pharmacol. 1992. PMID: 1375572

3

Antagonists of adenosine and alpha-2-adrenoceptors reverse the anticonvulsant effects of tizanidine in DBA/2 mice.

De Sarro GB, De Sarro A. De Sarro GB, et al. Among authors: de sarro a. Neuropharmacology. 1989 Mar;28(3):211-5. doi: 10.1016/0028-3908(89)90095-6. Neuropharmacology. 1989. PMID: 2566944

4

Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

De Sarro G, Ongini E, Bertorelli R, Aguglia U, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Eur J Pharmacol. 1994 Sep 1;262(1-2):11-9. doi: 10.1016/0014-2999(94)90022-1. Eur J Pharmacol. 1994. PMID: 7529182

5

Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.

De Sarro G, Renne S, Nava F, De Sarro A. De Sarro G, et al. Among authors: de sarro a. J Pharm Pharmacol. 1994 Dec;46(12):1017-22. doi: 10.1111/j.2042-7158.1994.tb03259.x. J Pharm Pharmacol. 1994. PMID: 7714713

6

Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.

De Sarro G, Ammendola D, Nava F, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Brain Res. 1995 Feb 6;671(1):131-40. doi: 10.1016/0006-8993(94)01328-f. Brain Res. 1995. PMID: 7728525

7

Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.

De Sarro GB, De Sarro A. De Sarro GB, et al. Among authors: de sarro a. Neuropharmacology. 1993 Jan;32(1):51-8. doi: 10.1016/0028-3908(93)90129-q. Neuropharmacology. 1993. PMID: 8094234

8

Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.

De Sarro G, Di Paola ED, Aguglia U, de Sarro A. De Sarro G, et al. Among authors: de sarro a. Pharmacol Biochem Behav. 1996 Sep;55(1):39-48. doi: 10.1016/0091-3057(96)00062-7. Pharmacol Biochem Behav. 1996. PMID: 8870036

9

1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice.

De Sarro G, Gitto R, Rizzo M, Zappia M, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Gen Pharmacol. 1996 Sep;27(6):935-41. doi: 10.1016/0306-3623(95)02147-7. Gen Pharmacol. 1996. PMID: 8909973

10

Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.

De Sarro G, Ongini E, Bertorelli R, Aguglia U, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Pharmacol Biochem Behav. 1996 Oct;55(2):281-7. doi: 10.1016/s0091-3057(96)00085-8. Pharmacol Biochem Behav. 1996. PMID: 8951966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters